Abstract
Overexpression of androgen receptors (AR) in PC-3 cell, and treatment of 5α-dihydrotestosterone in LNCaP cells lead to the suppression of VDR transactivation. Competition for shared coregulators between AR and VDR is one possible mechanism to explain the suppressive effect of androgen-AR signals on VDR activity. Among the AR coregulators we tested, ARA54, ARA70, supervillin, and gelsolin were found to enhance VDR transactivation. Further characterization of the interaction between ARA54 or ARA70 and VDR demonstrated a direct interaction between VDR and ARA70, but no association between ARA54 and VDR. The LXXLL motif of ARA70 is essential for interaction with VDR and partially responsible for its function as a coactivator of VDR. The suppression of VDR transactivation by AR signal was restored by overexpression of ARA70, but not ARA54. Together, ARA70 and ARA54 modulate VDR transactivation, and the competition for ARA70 mediates the suppressive effect of androgen-AR on VDR transactivation.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Hansen, C. M., Binderup, L., Hamberg, K. J., and Carlberg, C. (2001). Front Biosci. 6, D820-D848.
Johnson, C. S., Hershberger, P. A., and Trump, D. L. (2002). Cancer Metastasis Rev. 21, 147–158.
Zhuang, S. H., Schwartz, G. G., Cameron, D., and Burnstein, K. L. (1997). Mol. Cell Endocrinol. 126, 83–90.
Zhao, X. Y., Peehl, D. M., Navone, N. M., and Feldman, D. (2000). Endocrinology 141, 2548–2556.
Feldman, B. J. and Feldman, D. (2001). Nat. Rev. Cancer 1, 34–45.
Gregory, C. W., He, B., Johnson, R. T., et al. (2001). Cancer Res. 61, 4315–4319.
Nishimura, K., Ting, H. J., Harada, Y., et al. (2003). Cancer Res. 63, 4888–4894.
Lee, Y. F., Lin, W. J., Huang, J., et al. (2002). Cancer Res. 62, 6039–6044.
Kang, H. Y., Yeh, S., Fujimoto, N., and Chang, C. (1999). J. Biol. Chem. 274, 8570–8576.
Heinlein, C. A. and Chang, C. (2002). Endocr. Rev. 23, 175–200.
Ting, H. J., Yeh, S., Nishimura, K., and Chang, C. (2002). Proc. Natl. Acad. Sci. USA 99, 661–666.
Hsu, C. L., Chen, Y. L., Yeh, S., et al. (2003). J. Biol. Chem. 278, 23691–23698.
He, B., Minges, J. T., Lee, L. W., and Wilson, E. M. (2002). J. Biol. Chem. 277, 10226–10235.
Ito, K., Adachi, S., Iwakami, R., et al. (2001). Eur. J. Biochem. 268, 2725–2732.
Visakorpi, T. (1999). Ann. Chir. Gynaecol. 88, 11–16.
Zhao, X. Y., Ly, L. H., Peehl, D. M., and Feldman, D. (1999). Endocrinology 140, 1205–1212.
Bao, B. Y., Hu, Y. C., Ting, H. J., and Lee, Y. F. (2004). Oncogene 23, 3350–3360.
Yang, E. S., Maiorino, C. A., Roos, B. A., Knight, S. R., and Burnstein, K. L. (2002). Mol. Cell Endocrinol. 186, 69–79.
Christakos, S., Raval-Pandya, M., Wernyj, R. P., and Yang, W. (1996). Biochem. J. 316(Pt 2), 361–371.
Trueb, R. M. (2002). Exp. Gerontol. 37, 981–990.
Li, Y. C., Pirro, A. E., Amling, M., et al. (1997). Proc. Natl. Acad. Sci. USA 94, 9831–9835.
Yeh, S., Tsai, M. Y., Xu, Q., et al. (2002). Proc. Natl. Acad. Sci. USA 99, 13498–13503.
Kitazawa, R. and Kitazawa, S. (2002). Biochem. Biophys. Res. Commun. 290, 650–655.
Heinlein, C. A., Ting, H. J., Yeh, S., and Chang, C. (1999). J. Biol. Chem. 274, 16147–16152.
Rachez, C., Suldan, Z., Ward, J., et al. (1998). Genes Dev. 12, 1787–1800.
Author information
Authors and Affiliations
Corresponding author
Additional information
These two authors contributed equally to this paper.
Rights and permissions
About this article
Cite this article
Ting, HJ., Bao, BY., Hsu, CL. et al. Androgen-receptor coregulators mediate the suppressive effect of androgen signals on vitamin D receptor activity. Endocr 26, 1–9 (2005). https://doi.org/10.1385/ENDO:26:1:001
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1385/ENDO:26:1:001